MEDIVOZ: AN APPLICATION TO HELP THE USE OF OVER THE COUNTER DRUGS
DOI:
https://doi.org/10.14450/2318-9312.v32.e3.a2020.pp292-299Keywords:
nonprescription drugs, drug therapy, medication adherence, medicine package inserts, drug treatment, video-audio media.Abstract
The rate of use of Over the Counter (OTC) drugs is high in the population that uses drugs incorrectly or self-medicate without knowing the risks that this attitude can cause. The aim of this study was to create and test a mobile application, which allows the user to access an intuitive and accessible bulletin board, with direct and clear information about OTC. The MediVoz app was developed and registered at the National Institute of Industrial Property (INPI), process number 512018052096-0. Individuals of both sexes over 18 years old were interviewed; answered a questionnaire with questions about the use of OTC and the functionality of the MediVoz. It was observed that women have higher frequency of use of these drugs, (51.8%). When considering the salary, those who make frequent use of OTC receive up to 3 basic salary (52%). Of respondents, 36% said they rarely seek information about OTC before use, and 26% said they rarely receive information from the pharmacist about OTC they buy. Regarding the MediVoz application, 97% of respondents said they would use it when needing information about some OTC, and 98% thought Medivoz’s reading and pronunciation of information makes understanding easier. All participants respond that the Medivoz app makes clarify doubts about OTC. Thus, it is concluded that Medivoz has proved to be a practical and useful tool to answer questions about OTC.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).